In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival compared to placebo in patients with limited-stage small cell lung cancer ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

Researchers have unlocked a key in a person's immune response that could halt the spread of cancer the body cannot see.

Genprex intellectual property and licensing senior vice-president Thomas Gallagher stated: “We continue to bolster our intellectual property portfolio for REQORSA, understanding ...

In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...

A woman who was diagnosed with stage 4 lung cancer has revealed the biggest lie she was told about the disease, urging others ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...

Genprex (GNPX) announced it has entered into an exclusive license agreement with the University of Michigan, granting Genprex a worldwide, ...

When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...

The phase 3 MK-3475A-D77 trial tested subcutaneous and intravenous Keytruda given every six weeks in combination with ...

Merck & Co. Inc.'s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer drug Keytruda. Rahway, N.J.-based Merck (MRK) said a trial of the drug, given ...